🇺🇸 FDA
Pipeline program

IMFINZI 50 mg/mL concentrate for solution for infusion.

Phase 3 small_molecule active

Quick answer

IMFINZI 50 mg/mL concentrate for solution for infusion. for Small-cell lung cancer, extensive stage is a Phase 3 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
Ology Bioservices Ireland LTD
Indication
Small-cell lung cancer, extensive stage
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials